Form D — ABVC BIOPHARMA, INC.

0001213900-26-118072 · filed Nov 10, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $3,387,500
Reported amount sold: $3,387,500
Minimum investment: $125,000
Investors: 9
Sales commission: $237,125
Finders' fees: $0

Issuer

Name: ABVC BIOPHARMA, INC.
CIK: 1173313
Entity: Corporation
Jurisdiction: NEVADA
Year incorporated: —
Address: 44370 OLD WARM SPRINGS BLVD
FREMONT, CA 94538
Phone: (510) 500-9025

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Uttam Patil · Executive Officer

Fremont, CA Find on LinkedIn ↗
Eugene Jiang · Executive Officer

Fremont, CA Find on LinkedIn ↗
Tsung-Shann Jiang · Executive Officer

Fremont, CA Find on LinkedIn ↗
Tsang Ming Jiang · Director

Fremont, CA Find on LinkedIn ↗
Chang-Jen Jiang · Director

Fremont, CA Find on LinkedIn ↗
Norimi Sakamoto · Director

Fremont, CA Find on LinkedIn ↗
Yen-Hsin Chou · Director

Fremont, CA Find on LinkedIn ↗
Hsin-Hui Miao · Director

Fremont, CA Find on LinkedIn ↗
Yoshinobu Odaira · Director

Fremont, CA Find on LinkedIn ↗
Che-Wei Hsu · Director

Fremont, CA Find on LinkedIn ↗
Shuling Jiang · Director

Fremont, CA Find on LinkedIn ↗
Yu-Min (Francis) Chung · Director

Fremont, CA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗